2020/10/16 by Matthew Ragoza, Ragoza, Matthew, Tomohide Masuda +3 · 7 citations
Biochemistry, Genetics and Molecular Biology · Computer Science · Materials Science · #Biomolecules (q-bio.BM) #Computational Drug Discovery Methods #FOS: Biological sciences #FOS: Computer and information sciences #Graph Theory and Algorithms #Machine Learning (cs.LG) #Machine Learning in Materials Science #Protein Structure and Dynamics #Quantitative Methods (q-bio.QM) #cs.LG #q-bio.BM #q-bio.QM
paper · pdf · doi:10.48550/arxiv.2010.08687
Camera-ready submission to NeurIPS 2020 MLSB workshop
openalex publication_date 2020/10/16 · arxiv created 2020/11/15 · arxiv updated 2020/11/17 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28
Machine learning in drug discovery has been focused on virtual screening of molecular libraries using discriminative models. Generative models are an entirely different approach that learn to represent and optimize molecules in a continuous latent space. These methods have been increasingly successful at generating two dimensional molecules as SMILES strings and molecular graphs. In this work, we describe deep generative models of three dimensional molecular structures using atomic density grids and a novel fitting algorithm for converting continuous grids to discrete molecular structures. Our models jointly represent drug-like molecules and their conformations in a latent space that can be explored through interpolation. We are also able to sample diverse sets of molecules based on a given input compound and increase the probability of creating valid, drug-like molecules.